GTBP gtbiopharma.com: Stock Quotes

Public company logo of GT Biopharma Corp (GTBP)

GT Biopharma, Inc. (GTBP) operates on a specific oncology drug development cycle, where financial success is tied to tests of NK-cell activators against leukemia. The development of unique immuno-oncology agents with long-term patent protection will ensure the company's multi-year dominance and stable demand. This chart of share price action, which currently stands at 3.71, complements management's strategy to develop the TriKE platform and seek partners.

GTBP - GT Biopharma, Inc. Price Chart over the range 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for GT Biopharma Corp (GTBP)

- stock quotes and analyst forecast:
Comprehensive company analysis:GTBP GT Biopharma Corp
Brand item of GT Biopharma Inc

This indicator captures the market value of a single GT Biopharma, Inc. (GTBP) share at the close of trading, reflecting the current monetary consensus among investors regarding the business's capitalization. The price action on this linear chart correlates directly with the success of the TriKE platform and the results of lymphoma drug trials, where any price breakout signals a positive market revision of the company's fundamental value.